Lazabemide

From Self-sufficiency
Revision as of 21:09, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s): nervous-system-drug-stub)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Lazabemide
200px
Systematic (IUPAC) name
N-(2-aminoethyl)-5-chloro-pyridine-2-carboxamide
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 103878-84-8
ATC code none
PubChem CID 71307
ChemSpider 64426
Chemical data
Formula C8H10ClN3O
Molar mass 199.64 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Lazabemide (trade names Pakio, Tempium) is a reversible and selective inhibitor of monoamine oxidase B (MAO-B) which is used as an antiparkinsonian agent.[1]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



  1. Henriot S, Kuhn C, Kettler R, Da Prada M. (1994). "Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings". J Neural Transm Suppl. 41: 321–325. PMID 7931245.